NIH cuts to indirect rates, currently blocked by a federal judge, are already negatively affecting the stock of multiple companies. Yet industry does not speak up.
Existing synergy between Academia and industry is at risk.

https://www.genengnews.com/topics/omics/stockwatch-nih-indirect-cost-cuts-shake-tools-stocks/ via @GENbio

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service